To include your compound in the COVID-19 Resource Center, submit it here.

Gentium submits defibrotide NDA

Gentium S.p.A. (NASDAQ:GENT) submitted an NDA

Read the full 60 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE